Related Experiment Video
Updated: Jan 9, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
DEHP induces hepatic fibrosis through STAT3-SLC7A11-ROS axis
Siqin Liang1, Zhiliang Xu1, Xiaoxiang You2
1Department of Hepatobiliary Tumor Surgery, Department of Interventional Therapy, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang 330029, Jiangxi Province, China; Jiangxi Key Laboratory of Translational Cancer Research, Jiangxi Cancer Hospital of Nanchang University, Nanchang 330029, Jiangxi Province, China; Gannan Medical University, Ganzhou 341000, Jiangxi Province, China.
Di-(2-ethylhexyl) phthalate (DEHP) exposure triggers liver fibrosis by increasing reactive oxygen species (ROS). This occurs through the STAT3-SLC7A11 signaling pathway, offering new therapeutic targets for liver disease.
Area of Science:
- Environmental toxicology
- Molecular biology
- Hepatology
Background:
- Di-(2-ethylhexyl) phthalate (DEHP) is a common environmental contaminant linked to liver disease progression.
- The exact molecular mechanisms of DEHP-induced liver fibrosis are not fully understood.
Purpose of the Study:
- To investigate the effects of DEHP on liver fibrosis.
- To elucidate the underlying molecular mechanisms of DEHP-induced liver fibrosis.
Main Methods:
- Exposure of human hepatic stellate cells (HSCs) to DEHP.
- Analysis of fibrosis markers (α-SMA).
- Bioinformatic analysis including protein-protein interaction (PPI) network and pathway mapping.
- Molecular docking simulations.
- Assessment of reactive oxygen species (ROS) levels and SLC7A11 expression.
Main Results:
- DEHP exposure activated HSCs and upregulated α-SMA.
- DEHP-induced liver fibrosis is associated with ROS accumulation.
- DEHP binds to STAT3, downregulating SLC7A11 expression and promoting ROS accumulation via the STAT3-SLC7A11-ROS axis.
Conclusions:
- DEHP promotes liver fibrosis by inducing intracellular ROS accumulation through the STAT3-SLC7A11-ROS signaling pathway.
- This study identifies novel molecular targets for preventing and treating DEHP-induced liver fibrosis.
More Related Videos
08:56Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
10:42Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016